Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
26.06.2021 16:49:24
|
Johnson & Johnson Agrees To Settle New York Opioid Lawsuit : Reports
(RTTNews) - Johnson & Johnson agreed to pay hundreds of millions of dollars to settle opioid lawsuits filed in New York accusing the company of mishandling the highly addictive painkillers, according to several reports citing people familiar with the matter.
The settlement resolves cases brought by New York State Attorney General Letitia James and two Long Island counties that were set to go to trial next week, the reports said.
Johnson & Johnson's New York deal removes it from an upcoming trial on Long Island but not from the rest of the cases it faces nationwide, including an ongoing trial in California, the reports said.
As part of the New York settlement, the drugmaker has agreed to stop selling opioids nationwide.
The opioid crisis refers to the extensive overuse of opioid medications, both from medical prescriptions and from illegal sources. The crisis began in the United States in the late 1990s, when opioids were increasingly prescribed for pain management and resulted in a rise in overall opioid use throughout subsequent years.
From 1999 to 2017, more than 399,000 people reportedly died from drug overdoses that involved prescription and illicit opioids.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
03.04.25 |
Verluste in New York: So entwickelt sich der Dow Jones am Nachmittag (finanzen.at) | |
03.04.25 |
Zurückhaltung in New York: Dow Jones-Anleger ergreifen mittags die Flucht (finanzen.at) | |
02.04.25 |
Starker Wochentag in New York: Dow Jones zum Ende des Mittwochshandels im Plus (finanzen.at) | |
02.04.25 |
Dow Jones aktuell: Dow Jones klettert am Nachmittag (finanzen.at) | |
02.04.25 |
Pluszeichen in New York: Dow Jones liegt mittags im Plus (finanzen.at) | |
02.04.25 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Gewinn hätte ein Johnson Johnson-Investment von vor 10 Jahren abgeworfen (finanzen.at) | |
02.04.25 |
Angespannte Stimmung in New York: Dow Jones beginnt die Sitzung mit Verlusten (finanzen.at) | |
01.04.25 |
Börse New York: Dow Jones zeigt sich zum Ende des Dienstagshandels leichter (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 145,54 | 1,69% |
|